CELLBANKER is a series of cell cryopreservation media and has been our leading product since it became commercially available in 1991.
The medium achieves over 80% cell viability after thawing for most cell lines, and occupies over 70% of the share in experimental reagents in Japan. At present, we are developing novel applications of the CELLBANKER series to meet the needs of current research trends. In particular, the discovery of induced pluripotent stem cells (iPS cells) and related research efforts in recent years are leading the field of regenerative medicine as a novel industry to realize practical applications.

Regenerative medicine has opened new avenues for curing patients with difficult-to-treat diseases and diseases that are resistant to conventional therapies.

We are transforming the CELLBANKER series from being experimental in nature to being applicable in regenerative medicine in terms of quality and functionality, as well as addressing current issues with cryopreservation in basic research and clinical settings.